Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2024 Apr 19;17(4):525. doi: 10.3390/ph17040525

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© 2024 by the authors.

Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).

PMC Copyright notice

(A) Effects of GLP-1RA on weight, (B) effect of GLP-RA on glycemia levels, (C) effect of GLP-1RA on glucose level during OGTT, (D) effect of GLP-1RA on insulin level during OGTT, (E) effect of GLP-1RA on systolic blood pressure. Values are presented as mean ± SD. Statistical significance at the level * p < 0.05, ** p < 0.01. MetS: metabolic syndrome group. Exenatide: group of rats treated with exenatide. Dulaglutide; group of rats treated with dulaglutide. BDA: before drug administration. 3rd week of DA: third week of drug administration. Before: before OGTT (glucose administration) a, #—MetS vs. Exenatide; b, &—MetS vs. Dulaglutide.